Loading...

RELX Plc

RELXNYSE
$53.62
$-0.57(-1.05%)

RELX Plc (RELX) Stock Overview

Explore RELX Plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.7/100

Key Financials

Market Cap98.3B
P/E Ratio38.46
EPS (TTM)$1.41
ROE0.58%
Fundamental Analysis

AI Price Forecasts

1 Week$53.30
1 Month$55.21
3 Months$54.35
1 Year Target$58.82

RELX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of RELX Plc (RELX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $58.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.46 and a market capitalization of 98.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

51.39RSI (14)
0.07MACD
12.18ADX
Revenue Growth
2.98%
2.98%
Profit Growth
$1.03
8.59%
EPS Growth
$1.03
10.64%
Operating Margin
30.33%
6.67%
ROE
57.79%
8.59%
Dividend Yield
0.00%
7.32%

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0

Price Targets

Low$0.00
Average$0.00
High$0.00

Company Profile

RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the events business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.

CEO

Erik Engstrom Econ, MBA

Employees

34,580

Headquarters

1-3 Strand, London

Founded

1994

Frequently Asked Questions

;